NIH Guide: Weekly Index for September 25, 2020

Funding Opportunities

• State Occupational Safety and Health Surveillance Program (U60)
  (PAR-20-312)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): December 16, 2020; September 14, 2021; September 14, 2022 On-time submission requires that electronic applications be error-free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 5:00 PM Eastern Time on the listed application due date. Applicant organizations are strongly encouraged to start the registration process at least 4 weeks prior to the application due date Note: HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window)
• Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed)
  (RFA-AI-20-055)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): February 11, 2021
• Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)
  (RFA-CA-20-046)
  National Cancer Institute
  Application Receipt Date(s): December 15, 2020; December 14, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
• Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed)
  (RFA-DC-20-002)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): October 23, 2020; June 10, 2021; February 10, 2022; October 11, 2022; June 13, 2023 apply. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition for the Continuation of Clinical Centers to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis Consortium (U01 Clinical Trial Optional)
  (RFA-DK-20-504)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): December 16, 2020
• Limited Competition for the Continuation of the Scientific Data Research Center (SDRC) for the NIDDK Gastroparesis Consortium (U24 Clinical Trial Optional)
  (RFA-DK-20-505)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): December 16, 2020
• Limited Competition for Continuation of the Integrated Islet Distribution Program (U24 Clinical Trial Not Allowed)
  (RFA-DK-20-509)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): February 9, 2021
• Pediatric and Reproductive Environmental Health Scholars (PREHS): Strengthening the Pipeline (K12 Clinical Trial Not Allowed)
  (RFA-ES-20-007)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): January 15, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Using Syndemics to Understand HLBS Disease Emergence and Progression in People with HIV (PWH)(R01 Clinical Trial Not Allowed)
  (RFA-HL-21-018)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): See full announcement for details
• BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
  (RFA-MH-20-620)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): December 9, 2020; August 10, 2021, April 11, 2022, December 9, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01 Clinical Trial Not Allowed)
  (RFA-MH-20-701)
  National Institute of Mental Health
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date listed below.
• Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21 Clinical Trial Not Allowed)
  (RFA-MH-20-702)
  National Institute of Mental Health
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date listed below.